1. Home
  2. CFFN vs ESPR Comparison

CFFN vs ESPR Comparison

Compare CFFN & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capitol Federal Financial Inc.

CFFN

Capitol Federal Financial Inc.

HOLD

Current Price

$8.62

Market Cap

981.1M

Sector

Finance

ML Signal

HOLD

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.16

Market Cap

816.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFN
ESPR
Founded
1893
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
981.1M
816.9M
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
CFFN
ESPR
Price
$8.62
$3.16
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
$7.25
$8.75
AVG Volume (30 Days)
792.6K
9.9M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
4.51%
N/A
EPS Growth
79.31
60.71
EPS
0.32
N/A
Revenue
$16,300,000.00
$403,135,000.00
Revenue This Year
$20.16
N/A
Revenue Next Year
$6.62
$12.81
P/E Ratio
$26.59
N/A
Revenue Growth
6.54
21.31
52 Week Low
$5.71
$1.10
52 Week High
$8.58
$4.18

Technical Indicators

Market Signals
Indicator
CFFN
ESPR
Relative Strength Index (RSI) 71.05 63.17
Support Level $7.49 $3.13
Resistance Level N/A $3.18
Average True Range (ATR) 0.16 0.02
MACD 0.03 -0.02
Stochastic Oscillator 94.03 62.50

Price Performance

Historical Comparison
CFFN
ESPR

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: